Page 79 - Felix Nipkow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Felix nipkow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Felix Nipkow Today - Breaking & Trending Today

Chinese NMPA Approves Study of Telix Brain Cancer Therapy Candidate

MELBOURNE, Australia, April 11, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)today announces the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved a Phase I study of TLX101 investigational therapy (4-L-[131I] iodo-phenylalanine, or 131I-IPA) in Chinese patients with newly diagnosed glioblastoma (GBM). The investigational new drug (IND) application was submitted by Telix's partner in the Greater China region, Grand Pharmaceutical Group Limited (Grand Pharma). The Phase I study is required to establish the safety profile of this therapeutic candidate in a Chinese patient population, thus enabling Chinese patients to be enrolled in Telix's planned global pivotal registration trial for TLX101. This is the first of Telix's investigational therapies to move into a clinical trial with Grand Pharma. The IPAX-1 study of TLX101 (ClinicalTrials.gov Identifier: NCT03849105)met its primary objective d ....

Zhou Chao , United States , United Kingdom , Davidn Cade , Telix Asia Pacific , Kyahn Williamson , Telix Pharmaceuticals , Prnewswire Telix Pharmaceuticals Limited , Corporate Communications , Australian Securities Exchange , Chinese National Medical Products Administration , Australian Therapeutic Goods Administration , Group Limited Grand Pharma , Drug Administration , Health Canada , Pharmaceuticals Limited , Drug Evaluation , Greater China , Grand Pharmaceutical Group Limited , Grand Pharma , Asia Pacific , Telix Pharmaceuticals Limited , April 11 , 023 Prnewswire Telix Pharmaceuticals Limited Asx Tlx , He Company Today Announces The Chinese National Medical Products Administration Nmpa Center For Drug Evaluation Cde Has Approveda Phasei Study Of Tlx101 Investigational Therapy 4l 131i Iodo Phenylalanine , R 131i Ipa In Chinese Patients With Newly Diagnosed Glioblastoma Gbm The Investigational New Drug Ind Application Was Submitted By Telix 39s Partner Greater China Region ,

Lithium X Energy (CVE:LIX) Shares Up 0.8%

Lithium X Energy Corp. (CVE:LIX – Get Rating) shares rose 0.8% during mid-day trading on Thursday . The company traded as high as C$2.58 and last traded at C$2.57. Approximately 1,695,499 shares traded hands during mid-day trading, an increase of 204% from the average daily volume of 556,975 shares. The stock had previously closed at […] ....

United States , Los Angeles , News Ratings For Lithiumx Energy Daily , Lithiumx Energy Company Profile , Lithiumx Energy Price Performance , Royce Resources Corp , Lithiumx Energy Corp , Lithiumx Energy , Get Rating , Sal De Los Angeles , Salta Province , Royce Resources , Lithiumx Energy Daily , Cve Lix ,

Moving iMage Technologies Awarded Contract for New Flix Brewhouse Dine-In Cinema in Mansfield, Texas

Moving iMage Technologies , a leading cinema technology company, today announced it received an award from Flix Brewhouse for a nine-screen luxury dine-in theater in Mansfield, Texas.


We are. | April 6, 2023 ....

United States , Mage Technologies , Flix Brewhouse , Jerry Van De Rydt , Mansfield Flix Brewhouse , Moving Image Technologies , Nc Stock Exchange , Press Release , N Mitq Us62464r1095 ,